🔗 Share this article

Treasury head Reeves has stated she is planning "specific steps to deal with household expense challenges" in next month's Budget.

Speaking to media outlets, she noted that lowering price rises is a joint task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the G7 developed nations this calendar year and the following year.

Potential Utility Bill Measures

Sources suggest the government could take action to reduce utility costs, for instance by slashing the present 5% rate of value-added tax charged on energy supplies.

A further approach is to cut some of the policy costs currently added to household expenses.

Fiscal Limitations and Expert Expectations

The administration will obtain the next assessment from the official forecaster, the OBR, on Monday, which will clarify how much space there is for such actions.

The expectation from most analysts is that the Chancellor will have to announce higher taxes or spending cuts in order to meet her self-imposed fiscal targets.

Earlier on Thursday, estimates suggested there was a £22 billion deficit for the chancellor to resolve, which is at the more modest range of expectations.

"It is a collective task between the Bank of England and the government to bear down further on some of the sources of price increases," Reeves told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Issues

While much of the attention has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not changed her pledge to election pledges not to raise tax levels on earnings tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with rising geopolitical and commercial tensions for the Budget tax moves, probably to be targeted on those "most able to pay."

Global Economic Disputes

Addressing worries about the UK's economic relations with China she said: "The UK's security interests invariably come first."

Recent announcement by China to tighten trade restrictions on rare earths and other materials that are essential for advanced tech production led American leader Donald Trump to suggest an extra 100% import tax on imports from China, increasing the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese action "economic coercion" and "a global supply chain control attempt."

Asked about accepting the US offer to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the world economy and creates further headwinds."

"It is my opinion there are areas where we should address Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including financial services and other areas of the economic system. We've got to achieve that balance right."

The chancellor also confirmed she was cooperating with G7 counterparts "regarding our own essential resources approach, so that we are more independent."

NHS Drug Pricing and Funding

The Chancellor also admitted that the cost the NHS pays for medicines could increase as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

A number of the world's largest drug companies have said recently that they are either pausing or canceling projects in the UK, with several attributing the low prices they are receiving.

Last month, the Science Minister said the cost the health service spends on drugs would must go up to prevent companies and drug research funding departing from the UK.

The Chancellor stated to the BBC: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been offered in the United Kingdom in the extent that they are in other EU nations."

"We want to make sure that people getting treatment from the NHS are can access the top critical drugs in the world. And so we are looking at this situation, and... aiming to secure more investment into Britain."